PsyBio is continuing to increase its psycho-targeted patent portfolio, executing on its strategic priorities of innovation, development, and technology optimization PsyBio now has twenty patent applications in total OXFORD, Ohio and DENVER, Aug. 8, 2022 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (“PsyBio” or the “Company“), an intellectual property driven biotechnology company…
